- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Established in 1988, India Glycols Ltd. is engaged in the manufacturing of green technology-based bulk, specialty & performance chemicals, and natural gums, spirits, industrial gases, sugar, and nutraceuticals.
India Glycols has successfully demerged, creating three independent entities and allowing the parent company to sharpen its focus on bio-based specialty materials, sustainable performance chemicals, and gases. Post-demerger, the retained business reported FY26 net sales of ₹1,164 Cr, a decline from FY24's ₹1,581 Cr. However, Adjusted EBITDA significantly grew to...
India Glycols Limited (IGL) is undergoing a significant transformation post-demerger, now sharply focused on sustainable specialty chemicals. The demerger became effective on September 1, 2026, creating three independent entities for improved focus and capital allocation. **Business Performance:** For the retained IGL business, FY26 net sales were ₹1,164 Cr. While revenue...
IGL Spirits demonstrates strong performance, with total revenue growing at a 39% CAGR (FY24-26) to ₹2,801 Cr in FY26, driven by robust potable spirits and bio-fuels segments. EBITDA surged at a 48% CAGR (FY24-26) to ₹492 Cr, while potable spirits gross margins significantly improved to 45.9%. The company achieved a...
Ennature Biopharma, a natural ingredients platform, reported revenue of INR 246 Cr and EBITDA of INR 29 Cr for its recent fiscal year. The Plant-based API segment is the largest, contributing 67% of sales and providing stable cash flow, while Nutraceuticals (17%) and Biopolymers (16%) are key growth areas. The...